{"created":"2023-06-19T11:24:37.254624+00:00","id":5363,"links":{},"metadata":{"_buckets":{"deposit":"e51372be-9d3b-4892-a750-d98983428c81"},"_deposit":{"created_by":1,"id":"5363","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"5363"},"status":"published"},"_oai":{"id":"oai:asahikawa-med.repo.nii.ac.jp:00005363","sets":["7","7:24"]},"author_link":["16841","16843","16845","16840","16842","16844","16846"],"item_5_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015-01-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"87","bibliographicPageStart":"76","bibliographicVolumeNumber":"37","bibliographic_titles":[{"bibliographic_title":"Brain and Development"}]}]},"item_5_description_28":{"attribute_name":"識別番号 その他","attribute_value_mlt":[{"subitem_description":"PMID:24767548","subitem_description_type":"Other"}]},"item_5_description_33":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"BACKGROUND/AIMS:\n\\nAtomoxetine (ATX), a selective norepinephrine reuptake inhibitor, is the first approved non-stimulant drug for treatment of attention deficit/hyperactivity disorder (AD/HD). The present study examined the effects of long-term treatment with ATX on prefrontal hemodynamic activity in AD/HD children during a continuous performance task (CPT) using near-infrared spectroscopy (NIRS).\nMETHODS:\n\\nPrefrontal hemodynamic activity was measured in 12 children with AD/HD during experimental sessions conducted before and 6 months or more after starting ATX treatment. The average maintenance dose of ATX was 1.6 mg/kg/day. Fourteen age-matched typically developing children participated as a control group.\nRESULTS:\n\\nIn the control group, the CPT induced a significant increase in oxygenated hemoglobin (oxy-Hb) concentration in the bilateral dorsolateral prefrontal cortex (DLPFC). In the AD/HD group in the pre-ATX condition, the CPT did not induce a significant increase in oxy-Hb concentration in any of the NIRS channels, but induced a significant decrease in oxy-Hb concentration in the left ventrolateral prefrontal cortex (VLPFC). In the AD/HD group in the post-ATX condition, significant activation was observed in the right DLPFC and the decrease in oxy-Hb concentration in the left VLPFC disappeared.\nCONCLUSIONS:\n\\nThese results suggest that long-term treatment with ATX improved prefrontal hemodynamic activity in AD/HD children, and NIRS may be useful for assessment of the prefrontal hemodynamic response to ATX treatment.","subitem_description_type":"Abstract"}]},"item_5_description_36":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"著者最終原稿版","subitem_description_type":"Other"}]},"item_5_description_37":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"text","subitem_description_type":"Other"}]},"item_5_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_5_relation_24":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1016/j.braindev.2014.03.011","subitem_relation_type_select":"DOI"}}]},"item_5_source_id_22":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0387-7604","subitem_source_identifier_type":"ISSN"}]},"item_5_text_44":{"attribute_name":"ID(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"24767548"}]},"item_5_text_54":{"attribute_name":"閲覧数(XooNIps)","attribute_value_mlt":[{}]},"item_5_text_55":{"attribute_name":"ダウンロード数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"730"}]},"item_5_text_7":{"attribute_name":"著者 ローマ字","attribute_value_mlt":[{"subitem_text_value":"Araki, Akiko"},{"subitem_text_value":"Ikegami, Masanaga"},{"subitem_text_value":"Okayama, Akie"},{"subitem_text_value":"Matsumoto, Naoya"},{"subitem_text_value":"Takahashi, Satoru"},{"subitem_text_value":"Azuma, Hiroshi"},{"subitem_text_value":"Takahashi, Masaharu"}]},"item_5_version_type_38":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"荒木, 章子"},{"creatorName":"アラキ, アキコ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"池上, 将永"},{"creatorName":"イケガミ, マサナガ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"岡山, 亜貴恵"},{"creatorName":"オカヤマ, アキエ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"松本, 直也"},{"creatorName":"マツモト, ナオヤ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"高橋, 悟"},{"creatorName":"タカハシ, サトル","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"東, 寛"},{"creatorName":"アズマ, ヒロシ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"高橋, 雅治"},{"creatorName":"タカハシ, マサハル","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-07-06"}],"displaytype":"detail","filename":"6133.pdf","filesize":[{"value":"893.1 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"6133.pdf","url":"https://asahikawa-med.repo.nii.ac.jp/record/5363/files/6133.pdf"},"version_id":"a1905885-a6f9-4f20-852e-ef3e3d0e3fba"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Atomoxetine","subitem_subject_scheme":"Other"},{"subitem_subject":"Attention deficit/hyperactivity disorder","subitem_subject_scheme":"Other"},{"subitem_subject":"Continuous performance task","subitem_subject_scheme":"Other"},{"subitem_subject":"Near-infrared spectroscopy","subitem_subject_scheme":"Other"},{"subitem_subject":"Prefrontal cortex","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article"}]},"item_title":"Improved prefrontal activity in AD/HD children treated with atomoxetine: a NIRS study.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Improved prefrontal activity in AD/HD children treated with atomoxetine: a NIRS study."}]},"item_type_id":"5","owner":"1","path":["6","7","24"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-05-27"},"publish_date":"2015-05-27","publish_status":"0","recid":"5363","relation_version_is_last":true,"title":["Improved prefrontal activity in AD/HD children treated with atomoxetine: a NIRS study."],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-06-19T12:23:13.766185+00:00"}